Clinical manifestations of disorders of cellular energy metabolism in somatic diseases in children
https://doi.org/10.21508/1027-4065-2018-63-2-27-33
Abstract
The article presents current views on energy metabolism in a living cell, information on the mechanisms of its implementation in norm and in pathology. The methods of diagnostics of intracellular energy disturbances including the assessment of mitochondrial enzymes activity in blood lymphocytes, the level of total and bound carnitine using photoelectrocolorimetry and liquid tandem chromatomass spectrometry methods are discussed in detail. The main clinical manifestations of mitochondrial disorders are described: pathological manifestations on the part of the muscular and central nervous systems, the heart, other somatic organs, the polysystemic nature of lesions. The authors analyze the recent medical publications on the state of energy metabolism in different pathologies in children: with mitochondrial diseases, pathology of the digestive tract, urinary system, vegetovascular dystonia, etc. Data on the ways of correction of energy metabolism disorders using the energy-rich therapy are presented. It is convincingly shown that mitochondrial disorders require L-carnitine preparations in the form of monotherapy or in combination with other drugs.
About the Authors
I. I. Ivanova
Tver State Medical University, Tver
Russian Federation
Russian Federation
S. F. Gnusayev
Tver State Medical University, Tver
Russian Federation
Russian Federation
A. A. Ilyina
Tver State Medical University, Tver
Russian Federation
Russian Federation
References
1. Dumova S.V., Chugunova O.V. Correction of intracellular energy metabolism in premature neonates with intrauterine growth retardation. Pediatriya 2016; 95(1): 17–23. (in Russ)
2. Suhorukov V.S. Study of mitochondrial pathology. Moscow: MEDPRAKTIKA-M 2011; 288. (in Russ)
3. Neudahin E.V. The feasibility of using preparations of car-nitine in the treatment of chronic eating disorders in children. Praktika pediatra (Current Pediatrics) 2015; 2: 48–52. (in Russ)
4. Fujii T., Takada-Takatori Y., Kawashima K. Basic and clinical aspects of non-neuronal acetylcholine: expression of an independent, non-neuronal cholinergic system in lymphocytes and its clinical significance immunotherapy. J Pharmacol Sci 2008; 106: 186–192.
5. Neudahin E.V., Talickaya O.E. The feasibility of using preparations of carnitine in the treatment of vegetative dystonia syndrome in children. Praktika pediatra (Current Pediatrics) 2017; 1: 38–45. (in Russ)
6. Zaharova I.N., Tvorogova T.M., Stepurina L.L. Pshenichnikova I.I., Vorob’eva A.S., Kuznecova O.A. Vegetative dystonia in pediatric practice. Medicinskij sovet 2015; 14: 98–104. (in Russ)
7. Caregorodcev A.D., Suhorukov V.S. Mitochondrial medicine – problems and challenges. Ros vestn perinatol i pediatr 2012; 57(4/2): 4–13. (in Russ)
8. Volkov V.P., Gladilin G.P., Dzhodzhua A.G., Zaharchenko M.V., Kondrashova M.N., Litvinova E.G. et al. Innovative methods of diagnosis in medicine. V.P. Volkov (ed.). Novosibirsk: SibAK 2013; 150. (in Russ)
9. Ledyaev M.Ya., Zayachnikova T.E. The role of L-carnitine in the treatment of postnatal malnutrition in preterm infants after discharge from neonatal hospital. Vopr praktich pediatr 2017; 12(3): 7–12. (in Russ)
10. Tumaeva T.S., Balykova L.A., Piksajkina O.A., Garina S.V., Titkova O.E. Premature infants born through caesarean section: changes in the state at an early age when used in the complex therapy of the drug of l-carnitine. Voprosy prakticheskoj pediatrii 2016; 11(2): 31–37. (in Russ)
11. Brin I.L., Neudahin E.V., Dunajkin M.L. Carnitine in Pediatrics: research and clinical practice. Moscow: MEDPRAKTIKA-M 2015; 112. (in Russ)
12. Grishkevich N.Yu., Manchuk V.T., Savchenko A.A. Characteristics of metabolism and morphological composition of blood lymphocytes in children with obesity. First All-Russian Congress «Modern Technologies in Pediatrics and Pediatric Surgery». Moscow 2002; 74. (in Russ)
13. Nakostenko T.N., Klyuchnikov S.O., Suhorukov V.S. Correction of disorders of autonomic homeostasis and intracellular energy metabolism in frequently ill children. Vestn pediatr, farmakol i nutriciol 2007; 4(1): 25–29. (in Russ)
14. Nikolaeva E.A. Mitochondrial diseases in children: clinical manifestations, diagnostics and treatment. Tutorial. Moscow 2017; 88. (in Russ)
15. Kadurina T.I., Gorbunova V.N. Connective tissue dysplasia: a Guide for physicians. SPb: EHlbi-SPb 2009; 704. (in Russ)
16. Gnusaev S.F., Ivanova I.I., Samoshkina L.K., Shkvorova V.V., Lisicina S.V. Features of flow of diseases of the cardiovascular system in children with minor heart anomalies. Praktika pediatra 2016; 3: 5–9. (in Russ)
17. Ivanova I.I., Gnusaev S.F., Koval’ N.Yu., Gerasimov N.A., Sol-datova I.A. Metabolic aspects of undifferentiated connective tissue dysplasia in children. Ros vestn perinatol i pediatr 2012; 57(4): 103–111. (in Russ)]
18. Ivyanskij S.A., Balykova L.A., Shchekina N.V., Aritkina A.A., Varlashina K.A., Shirokova A.A. et al. Disorders of connective tissue in children and adolescents involved in sports. Consilium Medicum. Pediatriya 2016; 4: 94–101. (in Russ)
19. Kadurina T.I., Gnusaev S.F., Abbakumova L.N., Alimova I.L., Antonova N.S., Apenchenko Yu.S. et al. Inherited and multifactorial disorders of connective tissue in children: diagnostic algorithms and management. The project of the Russian recommendations. Pediatriya 2014: 93(5): Suppl: 1–40. (in Russ)
20. Chemodanov V.V., Krasnova E.E. Peculiarities of disease in children with connective tissue dysplasia. Ivanovo: GOU VPO IvGMA Roszdrava 2009; 140. (in Russ)
21. Hrushcheva N.A., Safronova L.E., Andreeva D.M., Mironova N.V. Features of flow of diseases of the urinary system on the background of undifferentiated connective tissue dysplasia. In: Pediatric aspects of connective tissue dysplasia: achievements and perspectives. Issue 1. S.F. Gnusaev, T.I. Kadurina, A.N. Semyachkina (eds). Moscow–Tver’–SPb: RG PRE100 2010; 295–302. (in Russ)
22. Smirnova E.V., Lobanov Yu.F., Skudarnov E.V. Peculiarities of erosive gastroduodenitis in children with connective tissue dysplasia. Vopr sovrem pediatr 2006; 5(4): 122–129 (in Russ)
23. Savis’ko A.A., Vasilenok A.V. Peculiarities of metabolic processes, characteristics of cardiac hemodynamics in children and adolescents with the syndrome of connective tissue dysplasia of heart. In: Pediatric aspects of connective tissue dysplasia: achievements and perspectives. Issue 2. S.F. Gnusaev, T.I. Kadurina, A.N. Semyachkina (eds). Moscow–Tver’–SPb: RG PRE100 2011; 250–255 (in Russ)
24. Ivanova I.I., Gnusaev S.F., Apenchenko Yu.S., Kapustina L.V., Gerasimov N.A., Soldatova I.A. Features of diseases of the digestive tract in children with connective tissue dysplasia. Vopr sovrem pediatr 2012; 11(5): 50–55. (in Russ)
25. Ziganshina A.A., Suhorukov V.S., Bulatov V.P. Mitochondrial dysfunction in children with reflux esophagitis. Ros vestn perinatol i pediatr 2017; 62(2): 88–92. (in Russ)
26. Ivanova I.I., Gnusaev S.F., Koval’ N.Yu. Features of flow of diseases of the urinary system in children with connective tissue dysplasia. Ros pediatrich zhurn 2012; 4: 32–36. (in Russ)
27. Uzunova A.N., Nazarova M.V. The influence of ergotropic of therapy on indices of heart rate variability in children with cerebral ischemia. Pediatriya 2015; 94(5): 51–57. (in Russ)
28. Garina S.V., Balykova L.A., Nazarova I.S., Belkina N.R., Gluhova E.S. Posthypoxic cardiopathy in newborns: new treatment options. Pediatriya 2017; 96(1): 28–36. (in Russ)
29. Balykova L.A., Ivyanskij S.A., Chigineva K.N. Actual problems of medical support of children’s sports. Ros vestn perinatol i pediatr 2017; 62(2): 6–11. (in Russ)
30. Baedilova M.T., Sumenko V.V., Suhorukov V.S., Lebed’kova S.E., Trusova O.YU. The effectiveness energotropic therapy in cellular energy metabolism in children with mitral valve prolapse. Ros vestn perinatol i pediatr 2017; 62(1): 74–80. (in Russ)
31. Kalambet E.I., Osmanov I.M., Suhorukov V.S., Shabel’nikova E.I., Khavkin А.I. Violation of cellular energy metabolism and their correction in diseases of the digestive system in children. Vopr praktich pediatr 2012; 2: 69–72. (in Russ)
32. Klyuchnikov S.O., Il’yashenko D.А., Klyuchnikov M.S. The rationale for the use of L-carnitine and coenzyme Q10 in adolescents. Current Pediatrics (Vopr Sovremen Pediatr) 2008; 7(4): 102–104. (in Russ)
33. Korovina N.A., Tvorogova T.M., Zaharova I.N., Tarasova A.A., Hrunova K.M. The effectiveness of therapy energotropic vegetative dystonia with cardiac changes in children and adolescents. Ross vestn perinatol i pediatr 2008; 53(6): 21–29. (in Russ)
34. Goncharova O.V., Kuranov G.V. Modern approaches to the treatment of frequently ill children. Praktika pediatra 2016; 1: 44–48. (in Russ)
35. Doronina T.N., Cherkasov N.S. Indicators of carnitine and amino acid metabolism in children with congenital heart defects. Ros vestn perinatol i pediatr 2012; 57(1): 31–32. (in Russ)
36. Parich S., Goldstein A., Koenig M.K., Scaglia F., Enns G.M., Saneto R. et al. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Sosiety. J Genet Med 2015; 17(9): 689–701. DOI: 10.1038/gim.2014.177.
Review
For citations:
Ivanova I.I., Gnusayev S.F., Ilyina A.A. Clinical manifestations of disorders of cellular energy metabolism in somatic diseases in children. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2018;63(2):27-33. (In Russ.) https://doi.org/10.21508/1027-4065-2018-63-2-27-33
Views:
1103
Email this article 